CorridorAlpha
Get in touch
All reports

Case study / Illustrative / 4 min read

Meridian Pension Trust: right-sizing a legacy cannabis allocation.

A fictional pension fund tests whether its early-era cannabis exposure still stands on today’s evidence.

For / Pension funds & asset owners

Written / 23 Oct 2026

Fictional case study. All named companies and countries in this article are invented. No real security, issuer or jurisdiction is being assessed. Not investment or legal advice.

The mandate

Meridian Pension Trust is an invented institutional investor. A decade ago it took an early position in listed cannabis operators; today the board wants to know whether that exposure still reflects the evidence — or simply the era in which it was built.

The fictional engagement asked one question in three parts: is the thesis current, is the risk understood at position level, and is there a disciplined process for adding or reducing exposure? The answer had to be auditable, not anecdotal.

What the review examined

The review separated story risk from price risk. Story risk asks whether regulated markets are expanding as assumed; price risk asks whether each holding can survive funding cycles, pricing pressure and regulatory change. Conflating the two is how concentrated positions linger.

Each holding was tested for cash resilience, concentration within its home market, licence quality and governance. The picture that emerged was less a sector call than a set of position-level verdicts: some assets earned their place, several did not.

The outcome

The board adopted explicit position limits, a quality screen for any future entry and a fixed review cadence tied to regulatory milestones rather than market sentiment. The allocation did not disappear; it became deliberate.

For any fiduciary, the lesson generalises: exposure created in one market era must be re-underwritten for the next. This case study is fictional and illustrates a review framework, not an actual mandate.

The decision lens

An allocation set by conviction should be re-set by evidence, on a schedule — not by headlines.

Further perspectives

Equity research

Short selling: when the growth story outruns the cash.

Read article

Policy brief

Veloria: legalisation is a starting line, not a policy outcome.

Read article

Investment strategy

A licence is not a moat: diligence beyond the permit.

Read article

Case study

The Republic of Aravelle: a regulator’s market workshop.

Read article

Case study

Ostveld Capital: testing a plant-touching conviction.

Read article